MARLEYLILLY competitors

Mr. Fadden has deep experience in customer service and distribution, having built a 25-year career at Aramark (NYSE: ARMK), where he most recently served as President of its Uniform Division. At Aramark, he was responsible for rental and direct sale uniform operations with nearly 17,000 employees and revenues in excess of $2.5 billion.

Paul Sturman joined The Nature’s Bounty Co. as President and Chief Executive Officer in September 2017. He is also a member of the Board of Directors of the Company. A proven, entrepreneurial, global executive, Paul brings to The Nature’s Bounty Co. 30+ years of success in delivering exceptional results in consumer driven businesses as measured by revenue and income growth, market share, organizational development and shareholder value. Recognized as a disciplined, decisive and authentic leader who builds businesses through insight, clear strategic vision and prioritization of effort, Paul places particular focus upon attracting and inspiring diverse teams to produce superior results. Paul is a risk-taker and change agent with a history of turning businesses around, creating and sustaining conditions for meaningful innovation, and transforming organizations organically and/or through M&A integration. Paul brings tangible industry experience to his new role having spent six years successfully leading Pfizer’s $3+ billion Consumer Healthcare business (formerly Wyeth), one of the largest over-the-counter (OTC) healthcare products companies in the world. He served as Global President and was responsible for all aspects of the business unit’s operations, including the development and marketing of major household brands such as Advil®, ChapStick®, and Robitussin® as well as vitamin and supplement brands. After integrating the business into Pfizer, Paul led the turnaround of what was a historically declining business to outpace industry consumption growth through organic growth, acquisitions and securing the licensing rights for the prescription to OTC switch of Nexium. Previously, Paul served as President, North America for Johnson & Johnson Consumer Health Care, where he was responsible for more than 30 brands, including Listerine®, Band-Aid®, Stayfree®, Monistat®, Rogaine®, Neosporin®, and Visine®. He began his marketing career with Warner-Lambert, stewarding brands like Trident sugarless gum, Dentyne Ice, Rolaids antacids, and Halls Cough drops. A well-regarded executive in the healthcare industry, Paul previously served as Chairman of the Consumer Healthcare Products Association (CHPA). He is currently a Trustee of the Foundation for Morristown Medical Center, one of “America’s Top 50 Hospitals” and is also on the Board of Directors of Tyme Inc., a clinical-stage biotechnology company using cellular metabolism and oxidative stress to develop cancer therapeutics with low toxicity profiles. Paul earned his Bachelor’s degree in Biology and Master’s degree in Business Administration from Bucknell University.

Christopher 'Chris' Koch is a President/CEO at New Era Cap. He has worked as VP:Sales at New Era Cap. Christopher works or has worked as BOARD MEMBER at Erie County Law Enforcement Foundation Inc.

Joseph D. Ennen was appointed as the Company’s Chief Executive Officer and as a director of the Company on April 1, 2019. Mr. Ennen joined the Company from Columbus Manufacturing, a food processing company specializing in artisanal salami and other prepared delicatessen meats, where he served as President and CEO from early 2015 until its sale to Hormel Foods in December 2017. Before joining Columbus Manufacturing, Mr. Ennen was Senior Vice President and General Manager of Own Brands at Safeway, Inc., a leading supermarket chain, from 2009-2015. Prior to Safeway, Mr. Ennen spent four years as an executive at Pepsico/Frito Lay Division, including Group Vice President, Innovation and Vice President Marketing, Core Brands. Previously, Mr. Ennen held various leadership roles and general management, marketing and finance positions with ConAgra Foods, Kellogg’s Company and General Mills. Mr. Ennen graduated from the University of Minnesota with a Bachelor of Science degree in business (Finance and Marketing majors) and an MBA (with concentrations in Marketing and Corporate Strategy) from the University of Michigan.

Joel Freet is a Global Director:Sales at Cutter & Buck and Chief Executive Officer at Cutter & Buck. He has worked as National Account Executive at Cutter & Buck, Head:Corporate Business at Cutter & Buck, and International Account Coordinator at Cutter & Buck. Joel studied at Washington University in St. Louis.